Semi-Automatic Aseptic Kit for TIL Isolation and Cryopreservation

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for isolating tumor-infiltrating lymphocytes (TILs) from tumors are labor-intensive, require strict aseptic conditions, and often result in cell damage due to oxygen deficiency and improper processing, leading to suboptimal viability and diversity of the final cellular product.

Innovation Solution

A semi-automatic aseptic tissue processing method using a single-use aseptic kit with interconnected modules for disaggregation, enrichment, and stabilization, which minimizes contamination and operator exposure, allowing for efficient processing and cryopreservation of TILs with reduced cell damage.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If manual isolation methods are used for TILs, then processing flexibility is maintained, but labor intensity increases and processing time extends

Engineering Contradiction:
Improveprocessing speedVSAvoidsystem complexity
Core Design Contradiction:
ProductivityVSDevice complexity

Solution Approach 1:

The system is divided into separate functional modules: a disaggregation module for tissue breakdown, an enrichment module for TIL isolation, and a stabilization module for cell preservation. Each module performs a specific function in the TIL processing workflow, enabling automated operation while maintaining modularity and ease of implementation.

Inventive Principle:
Principle #1Segmentation

2Reliability

If traditional processing methods are used, then equipment simplicity is maintained, but contamination risk increases and aseptic conditions become difficult to maintain

Engineering Contradiction:
Improvecontamination controlVSAvoidprocessing system complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The system extracts and isolates the TIL processing workflow into a closed automated system that operates independently from the external environment. The automated modules handle tissue disaggregation, enrichment, and stabilization within a controlled environment, eliminating the need for manual intervention and thereby maintaining strict aseptic conditions while reducing contamination risk.

Inventive Principle:
Principle #2Taking out (Extraction)

3Manufacturing precision

If prolonged processing is performed, then complete TIL isolation is achieved, but cell viability decreases due to oxygen deficiency and damage

Engineering Contradiction:
Improveisolation completenessVSAvoidcell damage
Core Design Contradiction:
Manufacturing precisionVSObject-affected harmful factors

Solution Approach 1:

The system performs preliminary stabilization of the isolated TILs immediately after enrichment by transferring them to a stabilization module containing preservation medium. This preliminary action prevents cell degradation and maintains viability by protecting cells from oxygen deficiency and damage during the processing workflow, enabling complete isolation without compromising cell health.

Inventive Principle:
Principle #10Preliminary action

4Ease of operation

If manual handling is used, then equipment simplicity is maintained, but operator exposure to hazardous materials increases

Engineering Contradiction:
Improveoperator safetyVSAvoidautomation system complexity
Core Design Contradiction:
Ease of operationVSDevice complexity

Solution Approach 1:

The automated system performs the entire TIL processing workflow independently without requiring operator intervention. The modules automatically execute disaggregation, enrichment, and stabilization procedures, eliminating operator exposure to hazardous biological materials while maintaining ease of operation through automated control and monitoring.

Inventive Principle:
Principle #25Self-service

Data Source

PatentUS20240067929A1Devices and methods for isolating tumor infiltrating lymphocytes and uses thereof
Publication Date: 2024.02.29 INSTIL BIO UK LTD
  • US20240067929A1 patent drawing
  • US20240067929A1 patent drawing
  • US20240067929A1 patent drawing

AI summary

The present invention provides methods for isolating and cryopreserving tumor infiltrating lymphocytes (TILs) and producing therapeutic populations of TILs, including methods via use of a kit and a semi-automatic device for aseptic disaggregation, enrichment, and cryopreservation of a resected tumor prior to expansion of the TIL population. The present invention also provides methods for expansion, and/or stabilization of TILs, for instance UTILs, compositions involving the same and methods of treatment involving the same.